Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist, Snail, Slug, and E-cadherin

Cancer Letters

Volumn 311, Issue 1, 2011, Pages 66-76

  Shah, Parag P ^a   Kakar, Sham S ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

EMT; Ovarian cancer; PTTG; TGF

Indexed keywords

COMPLEMENTARY DNA; SMALL INTERFERING RNA;

ADENOVIRUS INFECTION; ARTICLE; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; E CADHERIN GENE; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE CONTROL; GENE DELETION; GENE FUNCTION; GENE LOSS; HUMAN; HUMAN CELL; HYPOPHYSIS TUMOR; ONCOGENE; OVARY CANCER; PITUITARY TUMOR TRANSFORMING GENE; PRIORITY JOURNAL; SLUG GENE; SNAIL GENE; TGF BETA GENE; TWIST GENE; UPREGULATION; VIMENTIN GENE;

CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TWIST TRANSCRIPTION FACTOR; VIMENTIN;

GASTROPODA;

EID: 80052161558     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.033     Document Type: Article

References (54)

1. A. Jemal, R. Siegel, J. Xu, E. Ward, Cancer statistics, CA Cancer J. Clin. 2010.
2. Pei L., Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 1997, 11:433-441.
3. Zhang X., Horwitz G.A., Prezant T.R., Valentini A., Nakashima M., Bronstein M.D., Melmed S. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 1999, 13:156-166.
4. Lee I.A., Seong C., Choe I.S. Cloning and expression of human cDNA encoding human homologue of pituitary tumor transforming gene. Biochem. Mol. Biol. Int. 1999, 47:891-897.
5. Kakar S.S., Jennes L. Molecular cloning and characterization of the tumor transforming gene (TUTR1): a novel gene in human tumorigenesis. Cytogenet. Cell Genet. 1999, 84:211-216.
6. Panguluri S.K., Yeakel C., Kakar S.S. PTTG: an important target gene for ovarian cancer therapy. J. Ovarian. Res. 2008, 1:6.
7. Kakar S.S. Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). Gene 1999, 240:317-324.
8. Hamid T., Malik M.T., Kakar S.S. Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells. Mol. Cancer 2005, 4:3.
9. Zou H., McGarry T.J., Bernal T., Kirschner M.W. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999, 285:418-422.
10. Wang Z., Yu R., Melmed S. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol. 2001, 15:1870-1879.
11. Ishikawa H., Heaney A.P., Yu R., Horwitz G.A., Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J. Clin. Endocrinol. Metab. 2001, 86:867-874.
12. McCabe C.J., Boelaert K., Tannahill L.A., Heaney A.P., Stratford A.L., Khaira J.S., Hussain S., Sheppard M.C., Franklyn J.A., Gittoes N.J. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J. Clin. Endocrinol. Metab. 2002, 87:4238-4244.
13. Yamashita S., Miyagi C., Fukada T., Kagara N., Che Y.S., Hirano T. Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 2004, 429:298-302..
14. Ahmed, Thompson E.W., Quinn M.A. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J. Cell Physiol. 2007, 213:581-588.
15. D. Vergara, B. Merlot, J.P. Lucot, P. Collinet, D. Vinatier, I. Fournier, M. Salzet, Epithelial-mesenchymal transition in ovarian cancer, Cancer Lett. 291, 59-66.
16. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metast. Rev. 2009, 28:151-166.
17. Karreth F., Tuveson D.A. Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis. Cancer Biol. Ther. 2004, 3:1058-1059.
18. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2000, 2:84-89.
19. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
20. Moreno-Bueno G., Cubillo E., Sarrio D., Peinado H., Rodriguez-Pinilla S.M., Villa S., Bolos V., Jorda M., Fabra A., Portillo F., Palacios J., Cano A. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006, 66:9543-9556.
21. Alexander N.R., Tran N.L., Rekapally H., Summers C.E., Glackin C., Heimark R.L. N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. Cancer Res. 2006, 66:3365-3369.
22. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
23. Derynck R., Akhurst R.J. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat. Cell Biol. 2007, 9:1000-1004.
24. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
25. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
26. M. Murakami, M. Suzuki, Y. Nishino, and M. Funaba, Regulatory expression of genes related to metastasis by TGF-beta and activin A in B16 murine melanoma cells, Mol. Biol. Rep. 37, 1279-1286.
27. Kitagawa K., Murata A., Matsuura N., Tohya K., Takaichi S., Monden M., Inoue M. Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1. Int. J. Cancer 1996, 66:91-97.
28. Piek E., Moustakas A., Kurisaki A., Heldin C.H., ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 1999, 112(Pt 24):4557-4568.
29. Keshamouni V.G., Michailidis G., Grasso C.S., Anthwal S., Strahler J.R., Walker A., Arenberg D.A., Reddy R.C., Akulapalli S., Thannickal V.J., Standiford T.J., Andrews P.C., Omenn G.S. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome. Res. 2006, 5:1143-1154.
30. Kakar S.S., Malik M.T. Suppression of lung cancer with siRNA targeting PTTG. Int. J. Oncol. 2006, 29:387-395.
31. Panguluri S.K., Kakar S.S. Effect of PTTG on endogenous gene expression in HEK 293 cells. BMC Genom. 2009, 10:577.
32. El-Naggar S.M., Malik M.T., Kakar S.S. Small interfering RNA against PTTG: a novel therapy for ovarian cancer. Int. J. Oncol. 2007, 31:137-143.
33. Abbud R.A., Takumi I., Barker E.M., Ren S.G., Chen D.Y., Wawrowsky K., Melmed S. Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol. Endocrinol. 2005, 19:1383-1391.
34. El-Naggar S.M., Malik M.T., Martin A., Moore J.P., Proctor M., Hamid T., Kakar S.S. Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice. J. Endocrinol. 2007, 194:179-191.
35. Yilmaz M., Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metast. Rev. 2009, 28:15-33.
36. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7:131-142.
37. Oda H., Tsukita S., Takeichi M. Dynamic behavior of the cadherin-based cell-cell adhesion system during Drosophila gastrulation. Dev. Biol. 1998, 203:435-450.
38. Rosivatz E., Becker I., Specht K., Fricke E., Luber B., Busch R., Hofler H., Becker K.F. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol. 2002, 161:1881-1891.
39. Watanabe O., Imamura H., Shimizu T., Kinoshita J., Okabe T., Hirano A., Yoshimatsu K., Konno S., Aiba M., Ogawa K. Expression of Twist and Wnt in human breast cancer. Anticancer Res. 2004, 24:3851-3856.
40. Kwok W.K., Ling M.T., Lee T.W., Lau T.C., Zhou C., Zhang X., Chua C.W., Chan K.W., Chan F.L., Glackin C., Wong Y.C., Wang X. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 2005, 65:5153-5162.
41. Terauchi M., Kajiyama H., Yamashita M., Kato M., Tsukamoto H., Umezu T., Hosono S., Yamamoto E., Shibata K., Ino K., Nawa A., Nagasaka T., Kikkawa F. Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma. Clin. Exp. Metast. 2007, 24:329-339.
42. Kurrey N.K., Amit K., Bapat S.A. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol. Oncol. 2005, 97:155-165.
43. Elloul S., Silins I., Trope C.G., Benshushan A., Davidson B., Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch. 2006, 449:520-528.
44. Jiao W., Miyazaki K., Kitajima Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br. J. Cancer 2002, 86:98-101.
45. Yokoyama K., Kamata N., Hayashi E., Hoteiya T., Ueda N., Fujimoto R., Nagayama M. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral. Oncol. 2001, 37:65-71.
46. Poser I., Dominguez D., de Herreros A.G., Varnai A., Buettner R., Bosserhoff A.K. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J. Biol. Chem. 2001, 276:24661-24666.
47. Wang Z., Moro E., Kovacs K., Yu R., Melmed S. Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc. Natl. Acad. Sci. USA 2003, 100:3428-3432.
48. Chesnokova V., Kovacs K., Castro A.V., Zonis S., Melmed S. Pituitary hypoplasia in Pttg-/- mice is protective for Rb pituitary tumorigenesis. Mol. Endocrinol. 2005, 19:2371-2379.
49. Hasegawa Y., Takanashi S., Kanehira Y., Tsushima T., Imai T., Okumura K. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 2001, 91:964-971.
50. Saito H., Tsujitani S., Oka S., Kondo A., Ikeguchi M., Maeta M., Kaibara N. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999, 86:1455-1462.
51. Tsushima H., Kawata S., Tamura S., Ito N., Shirai Y., Kiso S., Imai Y., Shimomukai H., Nomura Y., Matsuda Y., Matsuzawa Y. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 1996, 110:375-382.
52. Do T.V., Kubba L.A., Du H., Sturgis C.D., Woodruff T.K. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol. Cancer Res. 2008, 6:695-705.
53. Grande M., Franzen A., Karlsson J.O., Ericson L.E., Heldin N.E., Nilsson M. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell Sci. 2002, 115:4227-4236.
54. Siegel P.M., Shu W., Cardiff R.D., Muller W.J., Massague J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 2003, 100:8430-8435.